NGC Update Service: March 9, 2015

March 9, 2015 New This Week Guideline Synthesis Cervical Cerclage New: includes recommendations from ACOG, RCOG, and SOGC. Guideline Summaries National Clinical Guideline Centre Acute heart failure: diagnosing and managing acute heart failure in adults. Multiple sclerosis: management of multiple sclerosis in primary and secondary care. This updates a previously published guideline summary. National Collaborating Centre for Mental Health Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. This updates a previously published guideline summary. U.S. Preventive Services Task Force Behavioral counseling interventions to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement. This updates a previously published guideline summary. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. This updates a previously published guideline summary. Screening for chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. This updates a previously published guideline summary. Announcements NGC Spotlight New research review added! Visit the AHRQ Evidence Reports page for a listing of reports produced under AHRQ's Evidence-based Practice Program and Effective Health Care Program. Health Awareness Topics - March 2015 National Colorectal Cancer Awareness Month (see related guidelines) National Endometriosis Awareness Month (see related guidelines) National Kidney Month (see related guidelines) National Nutrition Month (see related guidelines) Save Your Vision Month (see related guidelines) Conference News The Guidelines International Network North America (G-I-N NA)continues to sponsor a monthly webinar series on topics of interest to the North American guideline community. Information on upcoming webinars, as well as audio files and slides from past webinars, is available on the G-I-N Web site. U.S. Food and Drug Administration (FDA) Advisories March 3, 2015: Testosterone Products: FDA is requiring that the manufacturers of all approved prescription testosterone products change their labeling to clarify the approved uses of these medications. FDA is also requiring these manufacturers to add information to the labeling about a possible increased risk of heart attacks and strokes in patients taking testosterone. February 19, 2015: Endoscopic Retrograde Cholangiopancreatography (ERCP) Duodenoscopes: The FDA wants to raise awareness among health care professionals, including those working in reprocessing units in health care facilities, that the complex design of ERCP endoscopes (also called duodenoscopes) may impede effective reprocessing. Recent medical publications and adverse event reports associate multidrug-resistant bacterial infections in patients who have undergone ERCP with reprocessed duodenoscopes, even when manufacturer reprocessing instructions are followed correctly. Meticulously cleaning duodenoscopes prior to high-level disinfection should reduce the risk of transmitting infection, but may not entirely eliminate it. NGC's Sister Resource Look for Quality Measures in AHRQ's National Quality Measures Clearinghouse (NQMC).